Neoprobe names new chief development officer

11/18/2010 | MedCityNews.com

Neoprobe has designated Mark Pykett as its new chief development officer. Pykett was the founder of Talaris Advisors and was chief operating officer at Alseres Pharmaceuticals. Pykett will help the company in securing approval for its tracing agent Lymphoseek, as well as determine a collaborating firm for RIGScan, another tracing agent still in early development stages.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
PacificSource
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA